Spectral MD Announces BARDA Approval of Additional Funding of $20.6 Million to Execute DeepView Training Clinical Study for Burn Wounds
Share this article Share this article DALLAS, April 7, 2021 /PRNewswire/ -- Spectral MD announced today the execution of Option 1A of its contract with the Biomedical Advanced Research and Development Authority (BARDA), which will provide Spectral MD with an additional $20.6 million to execute the clinical training study of DeepView® Wound Imaging System for burn wound healing assessment. This contract option funding of $20.6 million follows the $27.3 million received from BARDA in July 2019 ...
United States Jeffrey Carter Contract Phase Human Services Biomedical Advanced Research Us Department Of Health
Source: prnewswire.com